BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 35491189)

  • 1. Biomimetic Nanoparticle Drug Delivery Systems to Overcome Biological Barriers for Therapeutic Applications.
    Fukuta T; Kogure K
    Chem Pharm Bull (Tokyo); 2022; 70(5):334-340. PubMed ID: 35491189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukocyte-mimetic liposomes possessing leukocyte membrane proteins pass through inflamed endothelial cell layer by regulating intercellular junctions.
    Fukuta T; Yoshimi S; Tanaka T; Kogure K
    Int J Pharm; 2019 May; 563():314-323. PubMed ID: 30978483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of DDS Actively to Overcome the Blood-brain Barrier in the Region of Ischemic Stroke].
    Fukuta T; Kogure K
    Yakugaku Zasshi; 2020; 140(8):1007-1012. PubMed ID: 32741858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of Biomembrane-mimetic Nanoparticles for the Treatment of Ischemic Stroke].
    Fukuta T
    Yakugaku Zasshi; 2021; 141(9):1071-1078. PubMed ID: 34471008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application and Utility of Liposomal Neuroprotective Agents and Biomimetic Nanoparticles for the Treatment of Ischemic Stroke.
    Fukuta T; Oku N; Kogure K
    Pharmaceutics; 2022 Feb; 14(2):. PubMed ID: 35214092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomimetic drug-delivery systems for the management of brain diseases.
    Chen YX; Wei CX; Lyu YQ; Chen HZ; Jiang G; Gao XL
    Biomater Sci; 2020 Feb; 8(4):1073-1088. PubMed ID: 31728485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell membrane-camouflaged nanoparticles for drug delivery.
    Luk BT; Zhang L
    J Control Release; 2015 Dec; 220(Pt B):600-7. PubMed ID: 26210440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hybrid cell membrane-coated nanoparticles: A multifunctional biomimetic platform for cancer diagnosis and therapy.
    Chen HY; Deng J; Wang Y; Wu CQ; Li X; Dai HW
    Acta Biomater; 2020 Aug; 112():1-13. PubMed ID: 32470527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor microenvironment-activated cancer cell membrane-liposome hybrid nanoparticle-mediated synergistic metabolic therapy and chemotherapy for non-small cell lung cancer.
    Zhang W; Gong C; Chen Z; Li M; Li Y; Gao J
    J Nanobiotechnology; 2021 Oct; 19(1):339. PubMed ID: 34689761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineering carrier nanoparticles with biomimetic moieties for improved intracellular targeted delivery of mRNA therapeutics and vaccines.
    Puccetti M; Pariano M; Schoubben A; Ricci M; Giovagnoli S
    J Pharm Pharmacol; 2024 Jun; 76(6):592-605. PubMed ID: 38092697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukocyte-Mimetic Liposomes Penetrate Into Tumor Spheroids and Suppress Spheroid Growth by Encapsulated Doxorubicin.
    Fukuta T; Yoshimi S; Kogure K
    J Pharm Sci; 2021 Apr; 110(4):1701-1709. PubMed ID: 33129835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell membrane coated nanocarriers - an efficient biomimetic platform for targeted therapy.
    Dash P; Piras AM; Dash M
    J Control Release; 2020 Nov; 327():546-570. PubMed ID: 32911013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coating nanoparticles with cell membranes for targeted drug delivery.
    Gao W; Zhang L
    J Drug Target; 2015; 23(7-8):619-26. PubMed ID: 26453159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell membrane-coated nanoparticles: a novel multifunctional biomimetic drug delivery system.
    Liu H; Su YY; Jiang XC; Gao JQ
    Drug Deliv Transl Res; 2023 Mar; 13(3):716-737. PubMed ID: 36417162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomimetics in drug delivery systems: A critical review.
    Sheikhpour M; Barani L; Kasaeian A
    J Control Release; 2017 May; 253():97-109. PubMed ID: 28322976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage membrane coated nanoparticles: a biomimetic approach for enhanced and targeted delivery.
    Khatoon N; Zhang Z; Zhou C; Chu M
    Biomater Sci; 2022 Mar; 10(5):1193-1208. PubMed ID: 35122479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomimetic fabrication of nanotherapeutics by leukocyte membrane cloaking for targeted therapy.
    Mohale S; Kunde SS; Wairkar S
    Colloids Surf B Biointerfaces; 2022 Nov; 219():112803. PubMed ID: 36084510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stem cell membrane-coated abiotic nanomaterials for biomedical applications.
    Ferreira-Faria I; Yousefiasl S; Macário-Soares A; Pereira-Silva M; Peixoto D; Zafar H; Raza F; Faneca H; Veiga F; Hamblin MR; Tay FR; Gao J; Sharifi E; Makvandi P; Paiva-Santos AC
    J Control Release; 2022 Nov; 351():174-197. PubMed ID: 36103910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oriented Assembly of Cell-Mimicking Nanoparticles via a Molecular Affinity Strategy for Targeted Drug Delivery.
    Xie J; Shen Q; Huang K; Zheng T; Cheng L; Zhang Z; Yu Y; Liao G; Wang X; Li C
    ACS Nano; 2019 May; 13(5):5268-5277. PubMed ID: 31022341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Functional Chimeric Nanoparticles by Membrane Fusion of Small Extracellular Vesicles and Drug-Encapsulated Liposomes.
    Fukuta T; Nishikawa A; Hiramachi A; Yamashita S; Kogure K
    Biol Pharm Bull; 2023; 46(8):1098-1104. PubMed ID: 37532560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.